Neuronetics

Yahoo Finance • 4 hours ago

Neuronetics (STIM) Q4 2025 Earnings Transcript

Image source: The Motley Fool. Date Tuesday, March 17, 2026 at 8:30 a.m. ET Call participants President and Chief Executive Officer — Keith J. Sullivan Incoming President and Chief Executive Officer — Dan Reavers Chief Financial Office... Full story

Yahoo Finance • 5 hours ago

Neuronetics Q4 Earnings Call Highlights

Neuronetics logo Key Points Board appointed Dan Reuvers as CEO effective March 23, as Neuronetics transitions leadership while continuing its strategy to operate a vertically integrated mental-health company combining NeuroStar technolog... Full story

Yahoo Finance • 23 hours ago

Pre-Market Earnings Report for March 17, 2026 : ESLT, GDS, TME, ATAT, CAAP, ASO, TSAT, HUYA, ABEO, STIM, ICCM, PSQH

The following companies are expected to report earnings prior to market open on 03/17/2026. Visit our Earnings Calendar for a full list of expected earnings releases. Elbit Systems Ltd. (ESLT)is reporting for the quarter ending Decembe... Full story

Yahoo Finance • 2 days ago

Quant snapshot: Micron, Babcock & Wilcox lead strong buys as Fold Holdings, Alvotech lag

Information technology, industrials and utilities are set to feature prominently in this week’s earnings calendar, with 249 companies scheduled to report. This week’s quant rankings highlight strong momentum among technology and industria... Full story

Yahoo Finance • 14 days ago

Neuronetics to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call

MALVERN, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc., (NASDAQ: STIM) (the “Company” or “Neuronetics”), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transfor... Full story

Yahoo Finance • last month

Top Midday Gainers

Teradata (TDC) shares soared more than 25% amid heavy trading after the company overnight reported a PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • last month

Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results

All values provided represent preliminary unaudited results Fourth quarter 2025 revenue of $41.8 million, representing 86% year-over-year growth on an as reported basis and 23% year-over-year growth on an adjusted pro forma basisFull year... Full story

Yahoo Finance • 4 months ago

TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression

MALVERN, Pa., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohe... Full story

Yahoo Finance • 5 months ago

Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence

MALVERN, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohe... Full story

Yahoo Finance • 5 months ago

Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call

MALVERN, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohe... Full story

Yahoo Finance • 6 months ago

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

MALVERN, Pa., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neuroh... Full story

Yahoo Finance • 7 months ago

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who su... Full story

Yahoo Finance • 7 months ago

Canaccord Genuity lowers Neuronetics stock price target on margin concerns

Investing.com - Canaccord Genuity lowered its price target on Neuronetics (NASDAQ:STIM) to $7.00 from $8.00 on Wednesday, while maintaining a Buy rating on the stock. The medical device company, with a market capitalization of $300 milli... Full story

Yahoo Finance • 7 months ago

Neuronetics adjusts 2025 gross margin guidance to 48%-50% as Greenbrook revenue mix rises

Earnings Call Insights: Neuronetics (STIM) Q2 2025 MANAGEMENT VIEW * CEO Keith Sullivan highlighted a strong second quarter, stating, “We had a strong second quarter at Neuronetics, both in terms of our ability to drive accelerated top... Full story

Yahoo Finance • 7 months ago

Neuronetics Inc (NASDAQ:STIM) Reports Mixed Q2 2025 Earnings: Revenue Beat Overshadowed by Wider-Than-Expected Loss

Neuronetics Inc (NASDAQ:STIM [https://www.chartmill.com/stock/quote/STIM/profile]) reported its second-quarter 2025 financial results, delivering mixed performance relative to analyst expectations. While revenue exceeded estimates, the com... Full story

Yahoo Finance • 7 months ago

Neuronetics GAAP EPS of -$0.15 misses by $0.07, revenue of $38.11M beats by $1.17M

* Neuronetics press release [https://seekingalpha.com/pr/20188747-neuronetics-reports-second-quarter-2025-financial-and-operating-results] (NASDAQ:STIM [https://seekingalpha.com/symbol/STIM]): Q2 GAAP EPS of -$0.15 misses by $0.07. * R... Full story

Yahoo Finance • 7 months ago

Neuronetics Reports Second Quarter 2025 Financial and Operating Results

Delivered $38.1 million total revenue in the quarter, representing 18% adjusted pro forma revenue growth Generated record Greenbrook clinic revenue of $23.0 million in the quarter Reduced cash used in operations to $3.5 million, beating... Full story

Yahoo Finance • 7 months ago

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

MALVERN, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever... Full story

Yahoo Finance • 8 months ago

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

MALVERN, Pa., July 30, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohe... Full story

Yahoo Finance • 8 months ago

Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call

MALVERN, Pa., July 22, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohe... Full story